U.S. Markets closed

Cystic Fibrosis-Focused Biotech Easily Tops First-Quarter Estimates

ALLISON GATLIN
Cystic Fibrosis-Focused Biotech Easily Tops First-Quarter Estimates

Vertex earnings of $1.14 a share on $857 million in sales beat the forecasts of Wall Street analysts when it reported late Tuesday. The biotech's stock advanced in after-hours action.